Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05038098
PHASE1

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

Sponsor: M.D. Anderson Cancer Center

View on ClinicalTrials.gov

Summary

This phase I finds out the possible benefits and/or side effects of using magnetic tracer FerroTrace and the fluorescent dye indocyanine green to identify the lymph nodes that cancer is most likely to have spread to in patients with gastric cancer that are undergoing gastrectomy. Using FerroTrace in combination with the indocyanine green dye may help researchers better detect the disease.

Official title: Magnetic Sentinel Lymph Node Mapping in Gastric Cancer, Safety and Feasibility Clinical Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-03-31

Completion Date

2027-02-02

Last Updated

2026-03-05

Healthy Volunteers

No

Interventions

PROCEDURE

Gastrectomy

Undergo surgery

DRUG

Indocyanine Green

Given peritumorally

OTHER

Iron Conjugated Polymers in Saline Suspension

Given peritumorally

Locations (1)

M D Anderson Cancer Center

Houston, Texas, United States